edgen-logo베타

에드와 채팅하기

Invest

Brief

Desk
다른 사람들

뉴스

탐색하기

포트폴리오
미션
팔로우하기

참여하기

EN
뒤로


healthcare: pharma뉴스

당신을 위해시장경제기술 및 인공지능암호화폐에너지의료 서비스홍콩 및 중국금융

제약

바이오테크놀로지

보건 서비스

의료 기기

Replimune's TUDRIQEV wins FDA approval with 24.2% response rate

Replimune's TUDRIQEV wins FDA approval with 24.2% response rate

Aug 14 2026, 12:34
Capricor shares double as FDA agrees to review Duchenne drug data

Capricor shares double as FDA agrees to review Duchenne drug data

Aug 14 2026, 11:06
EMA validates Pfizer-Valneva Lyme vaccine as efficacy tops 70%

EMA validates Pfizer-Valneva Lyme vaccine as efficacy tops 70%

Aug 14 2026, 05:30
China pharma sector surges 30% as institutions pile into innovative drugs

China pharma sector surges 30% as institutions pile into innovative drugs

Aug 14 2026, 00:17
FDA approves BMS's ZENBEXUS, first CELMoD, doubling MRD-negative CR to 41%

FDA approves BMS's ZENBEXUS, first CELMoD, doubling MRD-negative CR to 41%

Aug 13 2026, 21:31
Appeals court revives $6.7 billion Bristol Myers Celgene lawsuit

Appeals court revives $6.7 billion Bristol Myers Celgene lawsuit

Aug 13 2026, 17:10
MapLight Therapeutics raises $150 million to fund CNS drug trials

MapLight Therapeutics raises $150 million to fund CNS drug trials

Aug 13 2026, 13:36
OS Therapies secures FDA statistical meeting on 2.5-year survival data

OS Therapies secures FDA statistical meeting on 2.5-year survival data

Aug 13 2026, 13:05
Rigel launches VEPPANU, first FDA-approved PROTAC, at $29,400 monthly

Rigel launches VEPPANU, first FDA-approved PROTAC, at $29,400 monthly

Aug 13 2026, 12:38
Novo CEO sees obesity market beyond winner-take-all as 100 million untreated

Novo CEO sees obesity market beyond winner-take-all as 100 million untreated

Aug 13 2026, 10:40
Definium's DT120 meets Phase 3 GAD endpoint with 5.4-point HAM-A gain

Definium's DT120 meets Phase 3 GAD endpoint with 5.4-point HAM-A gain

Aug 13 2026, 10:36
Novo CEO defends Lilly suit as Wegovy pill tops 5 million

Novo CEO defends Lilly suit as Wegovy pill tops 5 million

Aug 13 2026, 00:37
Akeso wins third NMPA approval as ivonescimab cuts death risk 34%

Akeso wins third NMPA approval as ivonescimab cuts death risk 34%

Aug 12 2026, 15:44
Belite Bio wins FDA priority review for tinlarebant, PDUFA Feb 2027

Belite Bio wins FDA priority review for tinlarebant, PDUFA Feb 2027

Aug 12 2026, 14:05
Lilly sues six companies over black-market retatrutide sales

Lilly sues six companies over black-market retatrutide sales

Aug 12 2026, 10:05
BridgeBio beats Q2 revenue as Attruby sales surge 211% to $222.4M

BridgeBio beats Q2 revenue as Attruby sales surge 211% to $222.4M

Aug 11 2026, 18:08
United Laboratories wins FDA nod for obesity drug UBT48128

United Laboratories wins FDA nod for obesity drug UBT48128

Aug 11 2026, 15:11
CSPC Pharma monkeypox vaccine wins FDA nod as shares slip 0.7%

CSPC Pharma monkeypox vaccine wins FDA nod as shares slip 0.7%

Aug 10 2026, 15:18
Novo Nordisk taps AWS for AI drug push, 25,000 staff onboard

Novo Nordisk taps AWS for AI drug push, 25,000 staff onboard

Aug 10 2026, 13:12
Regeneron faces $11 billion wipeout lawsuit after melanoma trial fails

Regeneron faces $11 billion wipeout lawsuit after melanoma trial fails

Aug 10 2026, 12:37

기능
주식 및 암호화폐용 AI Copilot
가격 예측
후원 추적기
암호화폐 비교
메인 페이지
Markets
US Stocks
HK Stocks
Crypto
News
Analyst Moves
Market Moves
Hong Kong IPO
Earnings
AI & Technology
Macro & Policy
이용약관개인정보 처리방침사이트맵
© 2026 Edgen에서 제공edgen-logo